Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia

Journal: Science Advances

Published: 2020-08-01

DOI: 10.1126/sciadv.aaz9890

Affiliations: 5

Authors: 7

Go to article
Institutions Share
Duke Department of Biomedical Engineering (BME), United States of America (USA) 0.36
Duke Molecular Physiology Institute (DMPI), United States of America (USA) 0.36
Duke Department of Medicine, United States of America (USA) 0.14
Department of Nutritional Sciences and Toxicology (NST), UC Berkeley, United States of America (USA) 0.07
Duke Department of Pharmacology and Cancer Biology, United States of America (USA) 0.07

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER